N-Acetylcysteine for thrombotic thrombocytopenic purpura: Is a von Willebrand factor-inhibitory dose feasible in vivo?

Jake Shortt, Stephen Opat, Erica Michelle Wood

Research output: Contribution to journal › Letter › Other › peer-review

13 Citations (Scopus)

Original language	English
Pages (from-to)	2362 - 2363
Number of pages	2
Journal	Transfusion
Volume	54
Issue number	9
DOIs	https://doi.org/10.1111/trf.12787
Publication status	Published - 2014

Access to Document

10.1111/trf.12787

RM sElocation

Cite this

@article{3dabe19b36a34117a8e2542a88d31852,

title = "N-Acetylcysteine for thrombotic thrombocytopenic purpura: Is a von Willebrand factor-inhibitory dose feasible in vivo?",

author = "Jake Shortt and Stephen Opat and Wood, {Erica Michelle}",

year = "2014",

doi = "10.1111/trf.12787",

language = "English",

volume = "54",

pages = "2362 -- 2363",

journal = "Transfusion",

issn = "0041-1132",

publisher = "Wiley-Blackwell",

number = "9",

}

TY - JOUR

T1 - N-Acetylcysteine for thrombotic thrombocytopenic purpura: Is a von Willebrand factor-inhibitory dose feasible in vivo?

AU - Shortt, Jake

AU - Opat, Stephen

AU - Wood, Erica Michelle

PY - 2014

Y1 - 2014

UR - http://onlinelibrary.wiley.com.ezproxy.lib.monash.edu.au/doi/10.1111/trf.12787/abstract

U2 - 10.1111/trf.12787

DO - 10.1111/trf.12787

M3 - Letter

VL - 54

SP - 2362

EP - 2363

JO - Transfusion

JF - Transfusion

SN - 0041-1132

IS - 9

ER -